Member Info for upomega

Newkotb. Maybe this is what the company is waiting on. In terms of opening up new avenues. I would settle for that if that is the case.
Mani1. Thats a few more posts to go towards my 45.000

Newkotb. I hope it is going well. What i can not understand is that the crew working on it are not communicating non rns material via social media. Even if its just a weather update.At least it would attract possible new investors.

This clearly shows how undervalued we are maverick7. This inmv is why the message needs to be got out there more. Not only by the company but the house broker as well

I shouldn't worry about that. Maybe if more people posted some life would bought back into the share. At the end of the day i invest to make money. Not haveing it sat around doing nothing.

With only nine months to go until we realise approx 45 thous bod equiv a day. Then i would rather now that they just build up the cash.but pay good dividends going forward yielding five or six percent. For me thats going to be the reason to hold past next year

Kahunajim. Ig offer a facity to bed and isa.they will charge a fee. But it saves you selling shares in your trading account transfering funds then buying them back in your isa
Its worth calling them as you will need to put the instruction in soon for the tax year

At least im not the only one fed up of this. I think they need to do some knid of roadshow to promote the company.lets hope we are in line for a decent dividend

Another great day by the look of things.. on separate note. Am i rght in saying that production net to serica could be 33 thousand with r 3 and Columbus by year end. Then the following year 45 thousand.bod equiv

Quintuscurtis. I think alot of lth are beginning to lose patience now. Not only that but my feeling is that a good few of us are approaching an age where time is running out in terms of this.The bod are no spring chickens either. Maybe they would do better to invest the cash pile into a large o ang player. Shell or bp springs to mind.

Unless something has changed i do not think much will be happening with allergens. As per the response i received in June of last year. Below is a copy of the e-mail together with other questions i raised at that time.

Wed 10/06/2020 05:09

I will try to answer as many questions as I am permitted to – see below
Sent: 09 June 2020 17:54

Subject: Re: Returning to normal

I just have a couple of follow on questions re todays update
In terms of Moligic do you anticipate sales during the next quarter together with further sales from China re food tec – As we announced yesterday we have received our first sale for the Mologic test and with on-going activities in 15 countries then I think it would be fair to assume that we expect further sales in the next quarter. Similarly with China as we have announced we made shipments last FY and these will continue during this FY. The question is more the size of the forward orders, which will be driven when our partner receives the self-test approval and how quick they can then convert that to demand. They do however have demand for the lab test already.

Also how quickly would you envisage sales for poc re rtc after design freeze

Once design freeze is reached Abingdon will then complete the V&V activities and once that is complete we will tech transfer to the alva site. This I am afraid is price sensitive information and not something we have disclosed to date. We want to reach design freeze then provide appropriate update

Also are things still on track for who validation of cd4 advanced. – we are pleased with the progress to date with WHO pre-qual, but we are not in control of those timelines.

Sorry one more. Has allergens just been mothballed .Meaning they could be continued at a future date.

I think its highly unlikely that we would restart the development of the remaining allergens. We are committed to continue to supply the 69 allergens we have already CE marked. I also believe that we have better opportunities in the short and mid term with lateral flow products that will drive our revenue growth at a faster rate.

Due to the nature of the above questions I would fully understand if you cannot answer all of them.

Maybe if they did inform the market our share price would be trading at a more realustic level. Surely they could do this in some way .

Surely newkotb any approach should have been intimated via an rns.

Hopefully we will benefit by this. It is a shame that serica is now more likely to be taken over rather than rapidly expanding. Which back a long kept me holding.

Another one bites the dust. It is a shame that we could not have been the purchaser.

Vascular
My understanding is that work will commence on the following once all of Mologics products have been embedded as per the original agreements.
fwiw one question i raised via the company a number of months ago. Copy of e-mail enclosed.

We aren’t planning to work on Malaria as the price per test is very low, what we are planning to do is to develop tests that complement CD4 advanced disease such as TB and cryptococcosis. We plan to start these later this year once we have transferred all the COVID tests and they are into routine production.

I think it may be to do with columbus. Im sure someone will correct me if im wrong. Im more worried about r3 and now r2

Newkotb. Are you saying that it has definitely closed down.

Thats all we need. If it is how long will it be shut down

FIingers crossed that Omega are little more successful than beagle 2 was and completes its mission in full.

Billions of money will be going back into the system once people go back to work. So any test that can be used to stop lazy idiots from working is welcome inmo. As many have posted before. Testing is now the way forward.